Treatment of High-Risk Neuroblastoma in a Southeast Asian Hub of Medical Tourism

被引：0
|
作者：
Lee, A. [1 ]
Chui, C. H. [2 ]
Aung, L. [1 ]
Wong, W. [3 ]
机构：
[1] Mt Elizabeth Hosp, Childrens Haematol & Canc Ctr, Singapore, Singapore
[2] Mt Elizabeth Med Ctr, Surg Ctr Children, Singapore, Singapore
[3] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-375
引用
收藏
页码：S263 / S263
页数：1
相关论文
共 50 条
  • [1] Treatment of High-Risk Neuroblastoma
    Hizhnikov, A.
    Kazancev, A.
    Kerimov, P.
    Pimenov, R.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S447 - S447
  • [2] Treatment of High-Risk Neuroblastoma
    Sung, Kiwoong
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S3 - S3
  • [3] Treatment of High-Risk Neuroblastoma
    Krystal, Julie
    Foster, Jennifer H.
    CHILDREN-BASEL, 2023, 10 (08):
  • [4] Eflornithine for treatment of high-risk neuroblastoma
    Jiang, Jianxiong
    Yu, Ying
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (06) : 577 - 578
  • [5] High-Risk Neuroblastoma Treatment Review
    Smith, Valeria
    Foster, Jennifer
    CHILDREN-BASEL, 2018, 5 (09):
  • [6] Rethinking high-risk neuroblastoma treatment
    Cohn, Susan L.
    Pearson, Andrew D. J.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
  • [7] Identifying treatment response in high-risk Neuroblastoma
    Roels, F.
    Hero, B.
    Oberthuer, A.
    Berthold, F.
    Fisher, M.
    KLINISCHE PADIATRIE, 2011, 223 (03): : 197 - 197
  • [8] Treatment and outcomes of high-risk neuroblastoma in Southeast Asia: a single-institution experience and review of the literature
    Lee, Anselm Chi-Wai
    Chui, Chan Hou
    Kwok, Robert
    Lee, Kim Shang
    Fong, Chee Meng
    Wong, Wilfred Hing-Sang
    SINGAPORE MEDICAL JOURNAL, 2023, 64 (05) : 319 - 325
  • [9] New Therapeutic Targets for the Treatment of High-Risk Neuroblastoma
    Wagner, Lars M.
    Danks, Mary K.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 107 (01) : 46 - 57
  • [10] Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma
    Mora, Jaume
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (05) : 647 - 653
12345